POLR2A | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

47 results for “POLR2A”

Trials

View all 39 →

Polish Registry of Diabetes (PolReD)

10,000 participants · First posted Dec 8, 2020

Perceptions of Porta Celiac Vascular Model

22 participants · First posted May 20, 2020

Not yet recruiting

Efficacy of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL

152 participants · First posted Jun 4, 2024

Drugs

anti-FolRa iADC

Anti-FolRa iADC(Sutro Biopharma)

Organizations

ORION BIOTECHNOLOGY POLSKA SP Z O O

Poland

GEDEON RICHTER POLSKA SP Z O O

Poland

Pola Chemical Industries, Inc.

Japan

News

Non-Invasive Brush Biopsy Test Detects Oral Squamous Cell Carcinoma with 95.5% Accuracy in Under One Hour

Pretzel Therapeutics Unveils POLRMT as Novel Obesity Target with Promising Preclinical Results

Polatuzumab Vedotin Plus R-CHP Shows Promise in High-Risk DLBCL

Page 1 of 5